Trade ORIC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Oric Pharmaceuticals, Inc. (ORIC) is trading at US$13.54, down 1.43% today as of Aug 28, 10:58 EDT. The company has a market capitalisation of US$1.47B. Over the past 52 weeks, ORIC has traded between US$7.23 and US$14.93. On Syfe you can trade ORIC with $0 commission and add it to your watchlist.
| Previous close | US$13.74 |
|---|---|
| Market cap | US$1.47B |
| 52-week range | US$7.23 – US$14.93 |
| Volume | 1.06M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
Year: 2020
ORIC Pharmaceuticals Starts Phase 3 Trial of Rinzimetostat in Metastatic Prostate Cancer
Jul 14, 9:07 PM · MT Newswires
Top Premarket Decliners
Apr 1, 12:06 PM · MT Newswires
Wedbush Cuts Price Target on ORIC Pharmaceuticals to $17 From $20, Keeps Outperform Rating
Apr 1, 11:00 AM · MT Newswires
ORIC Pharmaceuticals to Launch Phase 3 Trial of Prostate Cancer Drug Candidate, Shares Falter
Mar 31, 9:28 PM · MT Newswires
Oric Pharmaceuticals, Inc. (ORIC) stock is trading at US$13.54, -1.43% from the previous close of US$13.74.
The market cap for Oric Pharmaceuticals, Inc. (ORIC) stock is approximately US$1.47B.
The 52-week high for Oric Pharmaceuticals, Inc. (ORIC) stock is US$14.93.
The 52-week low for Oric Pharmaceuticals, Inc. (ORIC) stock is US$7.23.
Oric Pharmaceuticals, Inc. (ORIC) does not currently pay a dividend.
Stay on top of ORIC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
